Phase I, open-label, single-center, multiple-dose, dose-escalation clinical study of SUO11248 (Sunitinib) in subjects with high-risk prostate cancer who have elected to undergo radical prostatectomy

✍ Scribed by Allan J. Pantuck; Nazy Zomorodian; Arie S. Belldegrun

• Book ID: 107555068
• Publisher: Springer
• Year: 2007
• Tongue: English
• Weight: 66 KB
• Volume: 8
• Category: Article
• ISSN: 1527-2737
• DOI: 10.1007/s11934-007-0014-8